Sharekhan is bullish on Dr. Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 5460 in its research report dated...

Another great quarter for Dr Reddy’s, but is it sustainable?

10.02 am | 27 Jan 2023 | Source: Moneycontrol.com

EMs are expected to remain the chief driver of top-line growth, driven by chronic therapies and biosimilars...

Dr Reddys Labs Consolidated December 2022 Net Sales at Rs 6,789.80 crore, up 27.19% Y-o-Y

11.00 pm | 25 Jan 2023 | Source: Moneycontrol.com

NULL...

Dr Reddys Labs Standalone December 2022 Net Sales at Rs 3,897.60 crore, up 12.01% Y-o-Y

10.44 pm | 25 Jan 2023 | Source: Moneycontrol.com

NULL...

Dr Reddy’s reports 77% growth in Q3 consolidated profit

4.25 pm | 25 Jan 2023 | Source: Moneycontrol.com

Dr Reddy's Q3 result: The drugmaker reported a 27% YoY increase in consolidated revenues at Rs 6,770 crore for the reported quarter....

Dr Reddy’s Q3 Preview | Sharp drop in net profit likely on slump in US revenues

12.22 pm | 24 Jan 2023

Revlimid sale contribution to US revenue likely to fall as it normalises, making for a muted December Quarter...

Buy Dr. Reddy’s Laboratories; target of Rs 5460: Sharekhan

6.01 pm | 22 Dec 2022 | Source: Moneycontrol.com

Sharekhan is bullish on Dr. Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 5460 in its research report dated...

Buy Dr Reddy’s Labs; target of Rs 5180: Motilal Oswal

7.05 pm | 01 Nov 2022 | Source: Moneycontrol.com

Motilal Oswal is bullish on Dr Reddy’s Labs recommended buy rating on the stock with a target price of Rs 5180 in its research report dated October ...

Buy Dr Reddy's Laboratories; target of Rs 5215: ICICI Direct

6.25 pm | 01 Nov 2022 | Source: Moneycontrol.com

ICICI Direct is bullish on Dr Reddy's Laboratories recommended buy rating on the stock with a target price of Rs 5215 in its research report dated...

Buy Dr. Reddy's Laboratories; target of Rs 4900: Prabhudas Lilladher

11.01 pm | 31 Oct 2022 | Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Dr. Reddy's Laboratories has recommended buy rating on the stock with a target price of Rs 4900 in its research ...

What does g-Revlimid launch mean for Dr Reddy’s margin trajectory?

10.11 am | 31 Oct 2022 | Source: Moneycontrol.com

Emerging markets, including India, would remain the chief driver of top-line growth...

Dr Reddys Labs Consolidated September 2022 Net Sales at Rs 6,331.80 crore, up 9.42% Y-o-Y

11.22 pm | 28 Oct 2022 | Source: Moneycontrol.com

NULL...

Dr Reddys Labs Standalone September 2022 Net Sales at Rs 4,880.30 crore, up 27.64% Y-o-Y

11.11 pm | 28 Oct 2022 | Source: Moneycontrol.com

NULL...

1 2

Quick Links for Dr Reddys Laboratories

Corporate Action
Board Meetings
AGM/EGM
Bonus
Rights
Splits
Dividends

Peer Comparison
Competition
Price
Price Performance
Market Cap
Net Sales
Net Profit
Total Assets
Historical Prices
Price of Dr Reddys Labs on previous budgets

Related Searches Dr Reddys Laboratories Stock Price, Dr Reddys Labs Stock Quote, Dr Reddys Labs Results , Dr Reddys Labs News .. More »

Follow moneycontrol

Facebook Twitter RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window

Explore Moneycontrol

Stocks A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

Mutual Funds A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

Invest in bonds online

Dr Reddys Laboratories